Cutter & CO Brokerage, Inc. Organon & Co. Transaction History

Cutter & CO Brokerage, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$31.66 - $38.9 $6,648 - $8,169	-210 Reduced 2.26%	9,082 $307,000
Q1 2022 May 03, 2022	SELL	$30.45 - $39.36 $10,809 - $13,972	-355 Reduced 3.68%	9,292 $325,000
Q4 2021 Feb 10, 2022	BUY	$28.67 - $37.13 $22,620 - $29,295	789 Added 8.91%	9,647 $294,000
Q3 2021 Nov 02, 2021	BUY	$28.63 - $35.64 $48,585 - $60,481	1,697 Added 23.7%	8,858 $290,000
Q2 2021 Aug 09, 2021	BUY	$28.45 - $38.0 $203,730 - $272,118	7,161 New	7,161 $217,000

813

201M

1.53M

1.07M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.91B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.